Literature DB >> 23878190

Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

Lei-Ya Fang1, Kouji Izumi, Kuo-Pao Lai, Liang Liang, Lei Li, Hiroshi Miyamoto, Wen-Jye Lin, Chawnshang Chang.   

Abstract

Infiltrating macrophages are a key component of inflammation during tumorigenesis, but the direct evidence of such linkage remains unclear. We report here that persistent coculturing of immortalized prostate epithelial cells with macrophages, without adding any carcinogens, induces prostate tumorigenesis and that induction involves the alteration of signaling of macrophage androgen receptor (AR)-inflammatory chemokine CCL4-STAT3 activation as well as epithelial-to-mesenchymal transition and downregulation of p53/PTEN tumor suppressors. In vivo studies further showed that PTEN(+/-) mice lacking macrophage AR developed far fewer prostatic intraepithelial neoplasia (PIN) lesions, supporting an in vivo role for macrophage AR during prostate tumorigenesis. CCL4-neutralizing antibody effectively blocked macrophage-induced prostate tumorigenic signaling and targeting AR via an AR-degradation enhancer, ASC-J9, reduced CCL4 expression, and xenografted tumor growth in vivo. Importantly, CCL4 upregulation was associated with increased Snail expression and downregulation of p53/PTEN in high-grade PIN and prostate cancer. Together, our results identify the AR-CCL4-STAT3 axis as key regulators during prostate tumor initiation and highlight the important roles of infiltrating macrophages and inflammatory cytokines for the prostate tumorigenesis. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23878190      PMCID: PMC3833080          DOI: 10.1158/0008-5472.CAN-12-3228

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

Review 1.  Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

Authors:  Michael Karin; Toby Lawrence; Victor Nizet
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

2.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.

Authors:  Daniel J Freeman; Andrew G Li; Gang Wei; Heng-Hong Li; Nathalie Kertesz; Ralf Lesche; Andrew D Whale; Hilda Martinez-Diaz; Nora Rozengurt; Robert D Cardiff; Xuan Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

3.  Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor.

Authors:  Kuo-Pao Lai; Shinichi Yamashita; Spencer Vitkus; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2011-12-01

4.  Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Hung-Ming Lam; Dan-Ping Hu; Shuk-Mei Ho; Ikenna C Madueke; Andre Kajdacsy-Balla; Gail S Prins
Journal:  Endocrinology       Date:  2011-03-22       Impact factor: 4.736

Review 5.  Prevalent mutations in prostate cancer.

Authors:  Jin-Tang Dong
Journal:  J Cell Biochem       Date:  2006-02-15       Impact factor: 4.429

Review 6.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

7.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

8.  Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.

Authors:  Ping Zhu; Sung Hee Baek; Eliot M Bourk; Kenneth A Ohgi; Ivan Garcia-Bassets; Hideki Sanjo; Shizuo Akira; Paul F Kotol; Christopher K Glass; Michael G Rosenfeld; David W Rose
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

9.  Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3.

Authors:  P Kaler; L Augenlicht; L Klampfer
Journal:  Oncogene       Date:  2009-08-24       Impact factor: 9.867

10.  Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.

Authors:  M Jiang; S Fernandez; W G Jerome; Y He; X Yu; H Cai; B Boone; Y Yi; M A Magnuson; P Roy-Burman; R J Matusik; S B Shappell; S W Hayward
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

View more
  58 in total

Review 1.  Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Authors:  Kiera Rycaj; Hangwen Li; Jianjun Zhou; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2017-04-11       Impact factor: 15.707

Review 2.  Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.

Authors:  Ian G Mills
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

3.  Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell-Mediated Immune Suppression and Tumor Progression.

Authors:  Camila R Consiglio; Olga Udartseva; Kimberly D Ramsey; Chioma Bush; Sandra O Gollnick
Journal:  Cancer Immunol Res       Date:  2020-07-13       Impact factor: 11.151

Review 4.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

5.  A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.

Authors:  Brian W Simons; Nicholas M Durham; Tullia C Bruno; Joseph F Grosso; Anthony J Schaeffer; Ashley E Ross; Paula J Hurley; David M Berman; Charles G Drake; Praveen Thumbikat; Edward M Schaeffer
Journal:  J Pathol       Date:  2015-02       Impact factor: 7.996

Review 6.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

7.  Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.

Authors:  Boyu Zhang; Oh-Joon Kwon; Gervaise Henry; Alicia Malewska; Xing Wei; Li Zhang; William Brinkley; Yiqun Zhang; Patricia D Castro; Mark Titus; Rui Chen; Mohammad Sayeeduddin; Ganesh V Raj; Ryan Mauck; Claus Roehrborn; Chad J Creighton; Douglas W Strand; Michael M Ittmann; Li Xin
Journal:  Mol Cell       Date:  2016-09-01       Impact factor: 17.970

8.  A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.

Authors:  Ricardo J Flores; Aaron J Kelly; Yiting Li; Manjula Nakka; Donald A Barkauskas; Mark Krailo; Lisa L Wang; Laszlo Perlaky; Ching C Lau; M John Hicks; Tsz-Kwong Man
Journal:  Cancer       Date:  2016-08-16       Impact factor: 6.860

9.  Inhibition of KPNA4 attenuates prostate cancer metastasis.

Authors:  J Yang; C Lu; J Wei; Y Guo; W Liu; L Luo; G Fisch; X Li
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

10.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.